0 Ratings

ID

12666

Description

MIPSO Comparative study of bacterial microbiota in the skin and intestines of psoriasis patients before and after systemic treatment with adalimumab or ustekinumab or ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. H. C. Thomas A. Luger

Keywords

  1. 12/8/15 12/8/15 -
  2. 7/25/16 7/25/16 -
Uploaded on

December 8, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    End of Study Psoriasis MIPSO EudraCT 2014-003022-40

    End of Study Psoriasis MIPSO EudraCT 2014-003022-40

    End of Study
    Description

    End of Study

    Patient number
    Description

    Patient number

    Data type

    text

    Date end of study
    Description

    Date end of study

    Data type

    date

    End of Study
    Description

    End of Study

    Data type

    text

    Early Study termination
    Description

    Early Study termination (if more than one, specify below)

    Data type

    integer

    End of Study Reason
    Description

    End of Study Reason

    Data type

    text

    Similar models

    End of Study Psoriasis MIPSO EudraCT 2014-003022-40

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    End of Study
    Patient number
    Item
    text
    Date end of study
    Item
    date
    Item
    text
    Code List
    End of Study
    CL Item
    regular end of study (1)
    CL Item
    early study termination (2)
    Item
    Early Study termination
    integer
    Code List
    Early Study termination
    CL Item
    Change of treatment required (1)
    CL Item
    Patient's request (2)
    CL Item
    Inclusion/exclusion criteria were injured, before initializing therapy (3)
    CL Item
    Inclusion/exclusion criteria were injured, after initializing therapy (4)
    CL Item
    Entering pregnancy (5)
    CL Item
    Disallowed concomitant medication required (6)
    CL Item
    The continued participation in the clinical trial is medically no longer justifiable (7)
    CL Item
    Time windows for visits could not be complied with (8)
    CL Item
    Lack of patient compliance (9)
    CL Item
    Cancelation of the entire study (10)
    CL Item
    other reason (11)
    End of Study Reason
    Item
    text

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial